Vertex Pharma (VRTX) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY26 Revenue Guidance
Go back to Vertex Pharma (VRTX) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY26 Revenue Guidance| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 525.73 -3.92 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $529.65 | 52 Week High | $134.71 | |||
| Open | $527.00 | 52 Week Low | $73.31 | |||
| Day High | $531.22 | P/E | N/A | |||
| Day Low | $520.08 | EPS | $-1.98 | |||
| Volume | 1,046,924 | |||||
